Memantine for the Prevention of Cognitive Dysfunction in Patients Receiving Whole-Brain Radiation Therapy (WBRT): First Report of RTOG 0614, a Placebo-controlled, Double-blind, Randomized Trial

Reporter: Annemarie Fernandes, MD
The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 29 de octubre del 2012

Translation for this article does not exist

Blogs

The Power of a Cancer Support Group
by Bob Riter
May 26, 2016